Your browser doesn't support javascript.
Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study.
Huang, Mao; Yang, Yi; Shang, Futai; Zheng, Yishan; Zhao, Wenjing; Luo, Liang; Han, Xudong; Lin, Aihua; Zhao, Hongsheng; Gu, Qing; Shi, Yi; Li, Jun; Xu, Xingxiang; Liu, Kexi; Deng, YiJun; Cao, Quan; Wang, Weiwei.
  • Huang M; Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yang Y; Department of Critical Care Medicine, Zhongda Hospital of Southeast University, Nanjing, China.
  • Shang F; Department of Critical Care Medicine, the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, China.
  • Zheng Y; Department of Critical Care Medicine, Nanjing No.2 Hospital, Nanjing, China.
  • Zhao W; Department of Critical Care Medicine, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Luo L; Department of Critical Care Medicine, Wuxi No. 2 People's Hospital, Wuxi, China.
  • Han X; Department of Critical Care Medicine, the Third People's Hospital of Nantong City, Affiliated to Nantong University, Nantong, China.
  • Lin A; Department of Critical Care Medicine, Suqian People's Hospital of Nanjing Gulou Hospital Group, Suqian, China.
  • Zhao H; Department of Critical Care Medicine, the Affiliated Hospital of Nantong University, Nantong, China.
  • Gu Q; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, the Affiliated of Nanjing University Medical School, Nanjing, China.
  • Shi Y; Department of Pulmonary and Critical Care Medicine, Nanjing Jinlin Hospital, Nanjing, China.
  • Li J; Department of Infectious Diseases, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Xu X; Department of Pulmonary and Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou, China.
  • Liu K; Department of Critical Care Medicine, Lianyungang First People's Hospital, Lianyungang, China.
  • Deng Y; Department of Critical Care Medicine, Yancheng First People's Hospital, Yancheng, China.
  • Cao Q; Department of Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: 2004caoquan@163.com.
  • Wang W; Department of Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: wangweiwei199203@163.com.
Am J Med Sci ; 360(2): 120-128, 2020 08.
Article in English | MEDLINE | ID: covidwho-457378
ABSTRACT

BACKGROUND:

We studied patients with coronavirus disease 2019 (COVID-19) infected by severe acute respiratory syndrome coronavirus 2, a virus that originated in Wuhan, China, and is spreading over the country including Jiangsu Province. We studied the clinical characteristics and therapies of severe cases in Jiangsu Province.

METHODS:

A multicenter retrospective cohort study was conducted to analyze clinical, laboratory data and treatment of 60 severe cases with COVID-19 infection in Jiangsu Province between January 24, 2020 and April 20, 2020. The improvement and deterioration subgroups were compared to identify predictors of disease progression.

RESULTS:

A total of 653 infected cases with COVID-19 were reported in Jiangsu Province, of which 60 severe cases were included in this study. Up until April 20, 2020, the mortality of severe patients was 0%. The median age was 57 years. The average body mass index of these patients was 25 kg/m². White blood cell counts decreased in 45.0% of patients, lymphopenia in 63.3%, thrombocytopenia in 13.3% and procalcitonin levels in 88.3% of the patients were less than 0.5 ng/mL. There were no statistically significant differences in immunoglobulin therapy and GCs therapy between the improvement and deterioration subgroups. Logistic regression analysis identified higher levels of troponin T (odds ratio [OR] 1.04; 95% confidence interval [CI] 1.00-1.08; P = 0.04), antiviral therapy with aerosol inhalation of interferon (OR 6.33; 95% CI 1.18-33.98; P = 0.03), and the application of non-invasive mechanical ventilation (OR 1.99; 95%CI 1.17-3.41; P = 0.01) as predictors of disease progression, whereas higher lymphocyte count (OR 0.11; 95% CI 0.02-0.57; P = 0.01) and early prone ventilation were associated with improvement (OR 0.11; 95% CI 0.01-0.98; P = 0.04).

CONCLUSIONS:

COVID-19 infection had a low mortality rate in Jiangsu Province, China. The higher levels of troponin T and lower lymphocyte count were predictors of disease progression. Early prone ventilation may be an effective treatment for severe cases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Am J Med Sci Year: 2020 Document Type: Article Affiliation country: J.amjms.2020.05.038

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Am J Med Sci Year: 2020 Document Type: Article Affiliation country: J.amjms.2020.05.038